186 related articles for article (PubMed ID: 17602935)
1. Body weight changes with beta-blocker use: results from GEMINI.
Messerli FH; Bell DS; Fonseca V; Katholi RE; McGill JB; Phillips RA; Raskin P; Wright JT; Bangalore S; Holdbrook FK; Lukas MA; Anderson KM; Bakris GL;
Am J Med; 2007 Jul; 120(7):610-5. PubMed ID: 17602935
[TBL] [Abstract][Full Text] [Related]
2. Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients.
Bell DS; Bakris GL; McGill JB
Diabetes Obes Metab; 2009 Mar; 11(3):234-8. PubMed ID: 18564334
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of beta-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI.
Fonseca V; Bakris GL; Bell DS; McGill JB; Raskin P; Messerli FH; Phillips RA; Katholi RE; Wright JT; Waterhouse B; Lukas MA; Anderson KM;
Diabet Med; 2007 Jul; 24(7):759-63. PubMed ID: 17451422
[TBL] [Abstract][Full Text] [Related]
4. beta-blocker use and diabetes symptom score: results from the GEMINI study.
McGill JB; Bakris GL; Fonseca V; Raskin P; Messerli FH; Phillips RA; Katholi RE; Wright JT; Iyengar M; Anderson KM; Lukas MA; Dalal MR; Bell DS
Diabetes Obes Metab; 2007 May; 9(3):408-17. PubMed ID: 17391169
[TBL] [Abstract][Full Text] [Related]
5. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.
Bakris GL; Fonseca V; Katholi RE; McGill JB; Messerli FH; Phillips RA; Raskin P; Wright JT; Oakes R; Lukas MA; Anderson KM; Bell DS;
JAMA; 2004 Nov; 292(18):2227-36. PubMed ID: 15536109
[TBL] [Abstract][Full Text] [Related]
6. The rationale and design of the Glycemic Effects in Diabetes Mellitus Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trial.
Bakris GL; Bell DS; Fonseca V; Katholi R; McGill J; Phillips R; Raskin P; Wright JT; Iyengar M; Holeslaw T; Anderson KM;
J Diabetes Complications; 2005; 19(2):74-9. PubMed ID: 15745836
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes.
Bakris GL; Fonseca V; Katholi RE; McGill JB; Messerli F; Phillips RA; Raskin P; Wright JT; Waterhouse B; Lukas MA; Anderson KM; Bell DS;
Hypertension; 2005 Dec; 46(6):1309-15. PubMed ID: 16286578
[TBL] [Abstract][Full Text] [Related]
8. Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus.
Bank AJ; Kelly AS; Thelen AM; Kaiser DR; Gonzalez-Campoy JM
Am J Hypertens; 2007 Jul; 20(7):777-83. PubMed ID: 17586413
[TBL] [Abstract][Full Text] [Related]
9. Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study.
Phillips RA; Fonseca V; Katholi RE; McGill JB; Messerli FH; Bell DS; Raskin P; Wright JT; Iyengar M; Anderson KM; Lukas MA; Bakris GL;
J Cardiometab Syndr; 2008; 3(4):211-7. PubMed ID: 19040589
[TBL] [Abstract][Full Text] [Related]
10. Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET).
Torp-Pedersen C; Metra M; Charlesworth A; Spark P; Lukas MA; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Remme WJ; Scherhag A;
Heart; 2007 Aug; 93(8):968-73. PubMed ID: 17237130
[TBL] [Abstract][Full Text] [Related]
11. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
12. The effect of beta-blocker use on cyclosporine level in cardiac transplant recipients.
Bader FM; Hagan ME; Crompton JA; Gilbert EM
J Heart Lung Transplant; 2005 Dec; 24(12):2144-7. PubMed ID: 16364863
[TBL] [Abstract][Full Text] [Related]
13. Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.
Al-Hesayen A; Azevedo ER; Floras JS; Hollingshead S; Lopaschuk GD; Parker JD
Eur J Heart Fail; 2005 Jun; 7(4):618-23. PubMed ID: 15921803
[TBL] [Abstract][Full Text] [Related]
14. Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial.
Wright JT; Bakris GL; Bell DS; Fonseca V; Katholi RE; McGill JB; Messerli FH; Phillips RA; Raskin P; Holdbrook FK; Lukas MA; Iyengar M
J Clin Hypertens (Greenwich); 2007 Nov; 9(11):842-9. PubMed ID: 17978591
[TBL] [Abstract][Full Text] [Related]
15. Beta-blockers have a beneficial effect upon endothelial function and microalbuminuria in African-American subjects with diabetes and hypertension.
Jawa A; Nachimuthu S; Pendergrass M; Asnani S; Fonseca V
J Diabetes Complications; 2008; 22(5):303-8. PubMed ID: 18413195
[TBL] [Abstract][Full Text] [Related]
16. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA;
Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
[TBL] [Abstract][Full Text] [Related]
17. Risk of new-onset diabetes mellitus associated with beta-blocker treatment for hypertension.
Fonseca V; Sharma PP; Shah M; Deedwania P
Curr Med Res Opin; 2011 Apr; 27(4):799-807. PubMed ID: 21306286
[TBL] [Abstract][Full Text] [Related]
18. Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study.
Jacob S; Rett K; Wicklmayr M; Agrawal B; Augustin HJ; Dietze GJ
J Hypertens; 1996 Apr; 14(4):489-94. PubMed ID: 8761899
[TBL] [Abstract][Full Text] [Related]
19. Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET.
Remme WJ; Torp-Pedersen C; Cleland JG; Poole-Wilson PA; Metra M; Komajda M; Swedberg K; Di Lenarda A; Spark P; Scherhag A; Moullet C; Lukas MA
J Am Coll Cardiol; 2007 Mar; 49(9):963-71. PubMed ID: 17336720
[TBL] [Abstract][Full Text] [Related]
20. Effect of carvedilol and metoprolol on blood pressure, blood flow, and vascular resistance.
Morgan T; Snowden R; Butcher L
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S124-9. PubMed ID: 2454358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]